Author(s):
Adsul Samruddhi Subhash, Ugale Vaishnavi Sanjay, Wable Madhuri Sanjay, Kardile Sayali Dadasaheb
Email(s):
samuadsul03@gmail.com
DOI:
10.52711/2349-2988.2024.00042 
Address:
Adsul Samruddhi Subhash*, Ugale Vaishnavi Sanjay, Wable Madhuri Sanjay, Kardile Sayali Dadasaheb
Swastyadarpan Pratishthan’s Shantiniketan College of Pharmacy, A/P. Dhotre (B.K.), Tal. Parner, Dist. Ahmednagar, Maharastra - 414304.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2024
ABSTRACT:
Newly Apparent SARS-COV-2 Variants The toxicity and contagiousness of the virus as well as the efficacy of digenetic techniques may be particularly concerning. effectiveness of vaccines Internationally, SARS-CoV delta forms have taken centre stage. WHO dubbed B.1.15219 omicron and classified it as a kind of concern on November 26, 2021? The molecular profile of the omicron type, which also has several mutations in common with the earlier VOC alpha, beta, and gamma kinds, is reviewed in this paper. The omicron type's pathogenicity, immunogenicity, and viral transmability caused widespread alarm at the time. In this article, we go over the identification and description of the omicron type. The five VOCs' spike mutations were analysed, and potential countermeasures to the dissemination of omicron-type vaccines based on the SARS spike protein were discussed. Omicron B.1 was initially identified in a patient in South Africa in mid-November 2021, and in a matter of weeks, it had spread to 87 nations worldwide. It had taken the place of the once-dominant Delta variant globally by the end of December. PCR instrument for pathogen detection, such as SARS-CoV-2. The previous VOC Alpha, Beta, and Gamma variants, which immediately sparked worries about viral transmissibility, pathogenicity, and immune evasion worldwide, share multiple mutations with the Omicron variant. Here, we discussed the Omicron variant's discovery and traits, compared the mutations that caused the spike in the five VOCs, and further discussed potential preventative and remedial measures for the Omicron variant's prevalence.
Cite this article:
Adsul Samruddhi Subhash, Ugale Vaishnavi Sanjay, Wable Madhuri Sanjay, Kardile Sayali Dadasaheb. Review on Omicron: How different variants of Concern of the SARS-Coronavirus-2 impacted the World. Research Journal of Science and Technology. 2024; 16(4):299-3. doi: 10.52711/2349-2988.2024.00042
Cite(Electronic):
Adsul Samruddhi Subhash, Ugale Vaishnavi Sanjay, Wable Madhuri Sanjay, Kardile Sayali Dadasaheb. Review on Omicron: How different variants of Concern of the SARS-Coronavirus-2 impacted the World. Research Journal of Science and Technology. 2024; 16(4):299-3. doi: 10.52711/2349-2988.2024.00042 Available on: https://rjstonline.com/AbstractView.aspx?PID=2024-16-4-4
REFERENCES:
1. Feng W, Zong W, Wang F, Ju S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Molecular Cancer. 2020 Dec; 19(1):1-4.
2. Saied AA, Metwally AA, Madkhali NA, Haque S, Dhama K. Egypt's COVID-19 recent happenings and perspectives: a mini-review. Frontiers in Public Health. 2021 Aug 16; 9:696082.
3. Drake JW, Holland JJ. Mutation rates among RNA viruses. Proceedings of the National Academy of Sciences. 1999 Nov 23; 96(24): 13910-3.
4. Ferreira C, Doursout MF, Balingit JS. Coronavirus Pandemics. In2000 Years of Pandemics: Past, Present, and Future. 2023 Feb 9 (pp. 143-222). Cham: Springer International Publishing.
5. Elliott P, Bodinier B, Eales O, Wang H, Haw D, Elliott J, Whitaker M, Jonnerby J, Tang D, Walters CE, Atchison C. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science. 2022 Mar 25;375(6587):1406-11.
6. Chen G, Lu H. Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Drug Discoveries and Therapeutics. 2022 Jun 30; 16(3):139-41.
7. Ayoub SS. Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action. Temperature. 2021 Oct 2;8(4):351-71.
8. Ali KA, Maity A, Roy SD, Pramanik SD, Das PP, Shaharyar MA. Insight into the mechanism of steroidal and non-steroidal anti-inflammatory drugs. InHow Synthetic Drugs Work 2023 Jan 1 (pp. 61-94). Academic Press
9. .Przybyła GW, Szychowski KA, Gmiński J. Paracetamol–An old drug with new mechanisms of action. Clinical and Experimental Pharmacology and Physiology. 2021 Jan; 48(1):3-19.
10. Irinmwinuwa EO, Unekwe PC, Egba EU, Metu EC, Cherech NC. Acetaminophen: Ancient drug with a novel analgesic mechanism of action. World Journal of Advanced Research and Reviews. 2022; 16(1):580-9.
11. Emon NU, Alam S, Rudra S, Al Haidar IK, Farhad M, Rana ME, Ganguly A. Antipyretic activity of Caesalpiniadigyna (Rottl.) leaves extract along with phytoconstituent’s binding affinity to COX-1, COX-2, and mPGES-1 receptors: In vivo and in silico approaches. Saudi Journal of Biological Sciences. 2021 Sep 1; 28(9):5302-9.
12. Strillacci A. RNA Interference and cyclooxygenase-2 (COX-2) regulation in colon cancer cells.
13. Brennan K, Liu H. Acetaminophen. In First Aid Perioperative Ultrasound: Acute Pain Manual for Surgical Procedures 2023 Mar 3 (pp. 107-125). Cham: Springer International Publishing.
14. Bannister K, Dickenson AH. Central nervous system targets: supraspinal mechanisms of analgesia. Neurotherapeutics. 2020 Jul;17(3):839-45.
15. Ibrahim T, Gebril A, Nasr MK, Samad A, Zaki HA, Nasr Sr M. Unlocking the Optimal Analgesic Potential: A Systematic Review and Meta-Analysis Comparing Intravenous, Oral, and Rectal Paracetamol in Equivalent Doses. Cureus. 2023 Jul 14;15(7).
16. Trastullo R. Development of Innovative Formulations for Paediatric Use.
17. Cingi C, Muluk NB. Quick Guide to Anaphylaxis. Springer International Publishing; 2020
18. Klompas M, Karan A. Preventing SARS-CoV-2 transmission in health care settings in the context of the omicron variant. JAMA. 2022 Feb 15;327(7):619-20.
19. Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, Molteni E. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. The Lancet. 2022 Apr 23; 399(10335):1618-24
20. Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review. Journal of Medical Virology. 2022 Jul; 94(7): 2969-76
21. Dudley MZ, Schwartz B, Brewer J, Kan L, Bernier R, Gerber JE, Ni HB, Proveaux TM, Rimal RN, Salmon DA. COVID-19 Vaccination Status, Attitudes, and Values among US Adults in September 2021. Journal of Clinical Medicine. 2022 Jun 28; 11(13): 3734.
22. Talbot TR, Hayden MK, Yokoe DS, Malani AN, Amer HA, Kalu IC, Logan LK, Moehring RW, Munoz-Price S, Palmore TN, Weber DJ. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations. Infection Control and Hospital Epidemiology. 2023 Jan;44(1):2-7
23. Sexton NR, Cline PJ, Gallichotte EN, Fitzmeyer E, Young MC, Janich AJ, Pabilonia KL, Ehrhart N, Ebel GD. SARS-CoV-2 entry into and evolution within a skilled nursing facility. Scientific Reports. 2023 Jul 19; 13(1): 11657.
24. Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, van Driel ML, Bawazeer GA, Jones MA, Hoffmann TC, Clark J, Beller EM, Glasziou PP. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews. 2023(1).
25. Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, Van Der Westhuizen HM, Von Delft A, Price A, Fridman L, Tang LH, Tang V. Evidence reviews of face masks against COVID-19. Proceedings of the National Academy of Sciences. 2021 Jan 26; 118(4): e2014564118
26. Bielska IA, Manis DR, Schumacher C, Moore E, Lewis K, Agarwal G, Mondoux S, Jewett L, Speicher DJ, Liu RH, Leyenaar M. Health Sector Responses to the COVID-19 Pandemic in Ontario, Canada-January to May 2020. Public Health Management/Zdrowie Publicznei Zarzadzanie. 2020 Jan 1;18(1)